Thyroid function in preterm infants and neurodevelopment at 2 years.


Journal

Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 19 12 2018
revised: 06 12 2019
accepted: 11 12 2019
pubmed: 23 2 2020
medline: 4 9 2020
entrez: 22 2 2020
Statut: ppublish

Résumé

Postnatal thyroid dysfunction is common in preterm infants but the relationship between mild dysfunction and neurodevelopment is unclear. Our aim is to describe the relationship between thyroid function and neurodevelopment. Cohort analysis. 1275 infants born under 31 weeks' gestation; there were no exclusion criteria. The infants were part of a UK daily iodine supplementation trial. Thyroid-stimulating hormone, thyroid-binding globulin and total thyroxine levels were measured in dried blood spots on postnatal days 7, 14, 28 and the equivalent of 34 weeks' gestation. Neurodevelopment was measured using the Bayley-III Scales of infant development at 2 years of age. No infant was identified as hypothyroid through routine screening. The 3% of infants consistently in the top decile of gestationally age-adjusted thyroid-stimulating hormone levels had a reduction in cognitive score of 7 Bayley units when compared with those not in the top decile (95% CI -13 to -1). A reduction in motor composite score of 6 units (95% CI -12 to <-0.1) and fine motor score of 1 unit (95% CI -2 to -0.1) was also identified. The 0.7% of infants consistently in the bottom decile of age-adjusted thyroxine levels had a reduction in motor composite score of 14 units (95% CI -25 to -2) and its two subset scores, fine and gross motor, of 2 units (95% CI respectively -4.5 to <-0.1 and -4.3 to -0.3). Preterm infants with consistent 'mild' thyroid dysfunction score less on neurodevelopmental tests at 2 years of age. Many of these infants will not be detected by current clinical protocols or screening programmes.

Identifiants

pubmed: 32079615
pii: archdischild-2018-316742
doi: 10.1136/archdischild-2018-316742
doi:

Substances chimiques

Thyrotropin 9002-71-5
Iodine 9679TC07X4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

504-509

Informations de copyright

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Fiona L R Williams (FLR)

Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK f.l.r.williams@dundee.ac.uk.

Alice Lindgren (A)

Medical Student, Medical School, Ninewells Hospital and Medical School, Dundee, UK.

Jennifer Watson (J)

Division of Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK.

Anita Boelen (A)

Neonatal Screening Laboratory, Laboratory of Endocrinology, Academic Medical Centre, Amsterdam, The Netherlands.

Timothy Cheetham (T)

Department of Paediatric Endocrinology, Institute of Human Genetics, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH